Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | STK16 |
| Upstream (Parents) |
|---|
| (<<) ADAM15 → STK16 |
| (<<) BZW1 → STK16 |
| (<<) CFL1 → STK16 |
| (<<) DUSP7 → STK16 |
| (<<) ELF4 → STK16 |
| (<<) ELOVL1 → STK16 |
| (<<) HSPA8 → STK16 |
| (<<) MAPKAP1 → STK16 |
| (<<) RAB5C → STK16 |
| (<<) RAC1 → STK16 |
| (<<) RHOB → STK16 |
| (<<) SH3KBP1 → STK16 |
| (<<) UBE2N → STK16 |
| Downstream (Children) |
|---|
| STK16 → AKT2 (>>) |
| STK16 → CCND3 (>>) |
| STK16 → CEBPD (>>) |
| STK16 → EPHA1 (>>) |
| STK16 → GPX2 (>>) |
| STK16 → HMGCS1 (>>) |
| STK16 → MAP2K4 (>>) |
| STK16 → MBOAT2 (>>) |
| STK16 → MPHOSPH6 (>>) |
| STK16 → MTSS1 (>>) |
| STK16 → NOTCH1 (>>) |
| STK16 → NUPR1 (>>) |
| STK16 → PRKCD (>>) |
| STK16 → SFN (>>) |
| STK16 → SFXN4 (>>) |
| STK16 → SOCS3 (>>) |
| STK16 → SPR (>>) |
| STK16 → SULF2 (>>) |
| STK16 → TMEFF2 (>>) |
| STK16 → TSPAN3 (>>) |
| STK16 → TUBA4A (>>) |
| STK16 → UBQLN2 (>>) |
| STK16 → VAV3 (>>) |
